{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:08:50Z","timestamp":1791295730183,"version":"4.1.0"},"reference-count":159,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"crossref","award":["BDA:RD06\/0003201"],"award-info":[{"award-number":["BDA:RD06\/0003201"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"crossref","award":["BDA:RD07\/0003510"],"award-info":[{"award-number":["BDA:RD07\/0003510"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Henry Lester Trust"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.pharmthera.2010.10.006","type":"journal-article","created":{"date-parts":[[2010,11,4]],"date-time":"2010-11-04T08:18:00Z","timestamp":1288858680000},"page":"307-320","source":"Crossref","is-referenced-by-count":88,"title":["Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas"],"prefix":"10.1016","volume":"129","author":[{"given":"Chen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanta J.","family":"Persaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.pharmthera.2010.10.006_bb0005","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/sj.bjp.0704625","article-title":"Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach","volume":"135","author":"Adami","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.10.006_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tips.2005.11.003","article-title":"In silico patent searching reveals a new cannabinoid receptor","volume":"27","author":"Baker","year":"2006","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2004.11.005","article-title":"Evidence for novel cannabinoid receptors","volume":"106","author":"Begg","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2826.2008.01682.x","article-title":"Cannabinoid type 1 receptor: another arrow in the adipocytes' bow","volume":"20","author":"Bellocchio","year":"2008","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.10.006_bb0025","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1124\/mol.63.4.908","article-title":"The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa\/fa rats and in cultured adipocyte cells","volume":"63","author":"Bensaid","year":"2003","journal-title":"Mol Pharmacol"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2010.10.006_bb0030","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejphar.2007.02.066","article-title":"Role of cannabinoid CB2 receptors in glucose homeostasis in rats","volume":"565","author":"Bermudez-Silva","year":"2007","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0035","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00125-007-0890-y","article-title":"Presence of functional cannabinoid receptors in human endocrine pancreas","volume":"51","author":"Bermudez-Silva","year":"2008","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/bbrc.1999.0254","article-title":"Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function","volume":"256","author":"Bisogno","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.pharmthera.2010.10.006_bb0045","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.2337\/db06-0812","article-title":"Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity","volume":"55","author":"Bluher","year":"2006","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0050","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0022-3565(24)37876-0","article-title":"Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses","volume":"287","author":"Bonhaus","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0055","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1042\/bj3120637","article-title":"Activation of mitogen-activated protein-kinases by stimulation of the central cannabinoid receptor Cb1","volume":"312","author":"Bouaboula","year":"1995","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0060","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1432-1033.1996.0704p.x","article-title":"Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor \u2014 involvement of both mitogen-activated protein kinase and induction of Krox-24 expression","volume":"237","author":"Bouaboula","year":"1996","journal-title":"Eur J Biochem"},{"issue":"5","key":"10.1016\/j.pharmthera.2010.10.006_bb0065","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00125-009-1283-1","article-title":"Kisspeptin stimulation of insulin secretion: mechanisms of action in mouse islets and rats","volume":"52","author":"Bowe","year":"2009","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.10.006_bb0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/sj.bjp.0706093","article-title":"The expanding field of cannabimimetic and related lipid mediators","volume":"144","author":"Bradshaw","year":"2005","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmthera.2010.10.006_bb0075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjp.0707481","article-title":"Novel cannabinoid receptors","volume":"152","author":"Brown","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmthera.2010.10.006_bb0080","doi-asserted-by":"crossref","first-page":"G1289","DOI":"10.1152\/ajpgi.00543.2005","article-title":"Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance","volume":"290","author":"Burdyga","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"14","key":"10.1016\/j.pharmthera.2010.10.006_bb0085","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.lfs.2005.05.039","article-title":"PPAR-[gamma]: a nuclear receptor with affinity for cannabinoids","volume":"77","author":"Burstein","year":"2005","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.10.006_bb0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(02)02830-3","article-title":"Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract","volume":"459","author":"Casu","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"6653","key":"10.1016\/j.pharmthera.2010.10.006_bb0095","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/39807","article-title":"The capsaicin receptor: a heat-activated ion channel in the pain pathway","volume":"389","author":"Caterina","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mce.2006.12.038","article-title":"Effects of cannabinoid receptors on skeletal muscle oxidative pathways","volume":"267","author":"Cavuoto","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbrc.2007.09.099","article-title":"The expression of receptors for endocannabinoids in human and rodent skeletal muscle","volume":"364","author":"Cavuoto","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0110","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/en.2006-1608","article-title":"A role for beta-cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release","volume":"148","author":"Chu","year":"2007","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.pharmthera.2010.10.006_bb0115","doi-asserted-by":"crossref","first-page":"PL113","DOI":"10.1016\/S0024-3205(98)00322-1","article-title":"Appetite suppression and weight loss after the cannabinoid antagonist SR141716","volume":"63","author":"Colombo","year":"1998","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.10.006_bb0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0269881104040237","article-title":"Repeated administration with Delta(9)-tetrahydrocannabinol regulates mu-opioid receptor density in the rat brain","volume":"18","author":"Corchero","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.pharmtox.40.1.491","article-title":"Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators","volume":"40","author":"Corton","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5","key":"10.1016\/j.pharmthera.2010.10.006_bb0130","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1006\/bbrc.2001.4482","article-title":"The tissue distribution and functional characterization of human VR1","volume":"281","author":"Cortright","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.pharmthera.2010.10.006_bb0135","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/dmrr.764","article-title":"CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health","volume":"23","author":"Cota","year":"2007","journal-title":"Diab\/Metab Res Rev"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0140","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI17725","article-title":"The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis","volume":"112","author":"Cota","year":"2003","journal-title":"J Clin Investig"},{"issue":"6","key":"10.1016\/j.pharmthera.2010.10.006_bb0145","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1210\/en.2009-0046","article-title":"Minireview: endocannabinoids and their receptors as targets for obesity therapy","volume":"150","author":"de Kloet","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0150","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.lfs.2005.05.055","article-title":"Minireview: cannabinoid signalling","volume":"78","author":"Demuth","year":"2006","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0155","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1471-4159.2001.00333.x","article-title":"Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus","volume":"77","author":"Derkinderen","year":"2001","journal-title":"J Neurochem"},{"issue":"20","key":"10.1016\/j.pharmthera.2010.10.006_bb0160","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","author":"Despres","year":"2005","journal-title":"N Engl J Med"},{"issue":"5090","key":"10.1016\/j.pharmthera.2010.10.006_bb0165","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0170","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0031-6997(25)06864-4","article-title":"Cannabinoid pharmacology","volume":"38","author":"Dewey","year":"1986","journal-title":"Pharmacol Rev"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2010.10.006_bb0175","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0005-2760(98)00042-3","article-title":"\u2018Endocannabinoids\u2019 and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance","volume":"1392","author":"Di Marzo","year":"1998","journal-title":"Biochim Et Biophys Acta Lipids Lipid Metab"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.phrs.2009.02.010","article-title":"The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation","volume":"60","author":"Di Marzo","year":"2009","journal-title":"Pharmacol Res"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2010.10.006_bb0185","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1054\/plef.2001.0349","article-title":"Anandamide receptors","volume":"66","author":"Di Marzo","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"S2","key":"10.1016\/j.pharmthera.2010.10.006_bb0190","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/ijo.2009.67","article-title":"The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation","volume":"33","author":"Di Marzo","year":"2009","journal-title":"Int J Obes"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0195","unstructured":"Diabetes Atlas, 4th Edition. (2009). International Diabetes Federation."},{"issue":"8","key":"10.1016\/j.pharmthera.2010.10.006_bb0200","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2036.2005.02648.x","article-title":"Review article: endocannabinoids and their receptors in the enteric nervous system","volume":"22","author":"Duncan","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0205","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejphar.2009.05.024","article-title":"Beneficial effect of a chronic treatment with rimonabant on pancreatic function and \u03b2-cell morphology in Zucker Fatty rats","volume":"616","author":"Duvivier","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.10.006_bb0210","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s00125-008-1240-4","article-title":"Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle","volume":"52","author":"Eckardt","year":"2009","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.pharmthera.2010.10.006_bb0215","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.2337\/diabetes.54.10.2838","article-title":"Activation of the peripheral endocannabinoid system in human obesity","volume":"54","author":"Engeli","year":"2005","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.10.006_bb0220","doi-asserted-by":"crossref","first-page":"G137","DOI":"10.1152\/ajpgi.00565.2006","article-title":"Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study","volume":"293","author":"Esfandyari","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0225","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0026-895X(25)10492-6","article-title":"Comparison of the pharmacology and signal-transduction of the human cannabinoid Cb1 and Cb2 receptors","volume":"48","author":"Felder","year":"1995","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmthera.2010.10.006_bb0230","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0026-895X(25)09174-6","article-title":"Cannabinoid agonists stimulate both receptor-mediated and nonreceptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones","volume":"42","author":"Felder","year":"1992","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0235","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0092-8674(03)01081-X","article-title":"Obesity wars: molecular progress confronts an expanding epidemic","volume":"116","author":"Flier","year":"2004","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0240","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0014-5793(03)01196-7","article-title":"Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives","volume":"554","author":"Fredriksson","year":"2003","journal-title":"FEBS Lett"},{"issue":"6953","key":"10.1016\/j.pharmthera.2010.10.006_bb0245","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","article-title":"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-[alpha]","volume":"425","author":"Fu","year":"2003","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0250","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s002130050893","article-title":"The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716","volume":"142","author":"Gallate","year":"1999","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2010.10.006_bb0255","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1006\/nbdi.1998.0219","article-title":"Cannabinoid transmission and reward-related events","volume":"5","author":"Gardner","year":"1998","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0260","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/mol.105.015040","article-title":"The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes","volume":"69","author":"Gary-Bobo","year":"2006","journal-title":"Mol Pharmacol"},{"issue":"10","key":"10.1016\/j.pharmthera.2010.10.006_bb0265","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/oby.2009.234","article-title":"The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets","volume":"17","author":"Getty-Kaushik","year":"2009","journal-title":"Obesity"},{"issue":"14","key":"10.1016\/j.pharmthera.2010.10.006_bb0270","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a G(s) linkage to the CB1 receptor","volume":"17","author":"Glass","year":"1997","journal-title":"J Neurosci"},{"issue":"3\u20134","key":"10.1016\/j.pharmthera.2010.10.006_bb0275","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.prostaglandins.2009.07.001","article-title":"Receptors for acylethanolamides \u2014 GPR55 and GPR119","volume":"89","author":"Godlewski","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"21","key":"10.1016\/j.pharmthera.2010.10.006_bb0280","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1523\/JNEUROSCI.22-21-09612.2002","article-title":"A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding","volume":"22","author":"Gomez","year":"2002","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.10.006_bb0285","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/oby.2007.581","article-title":"Identification of endocannabinoids and related compounds in human fat cells","volume":"15","author":"Gonthier","year":"2007","journal-title":"Obesity"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.10.006_bb0290","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0006-2952(98)00314-1","article-title":"Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors","volume":"57","author":"Goparaju","year":"1999","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.10.006_bb0295","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00427475","article-title":"Effects of marihuana use on body-weight and caloric intake in humans","volume":"49","author":"Greenberg","year":"1976","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/j.pharmthera.2010.10.006_bb0300","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc1188","article-title":"Cannabinoids: potential anticancer agents","volume":"3","author":"Guzman","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"27","key":"10.1016\/j.pharmthera.2010.10.006_bb0305","doi-asserted-by":"crossref","first-page":"27849","DOI":"10.1074\/jbc.M404087200","article-title":"Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor-alpha (PPAR-alpha)","volume":"279","author":"Guzman","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.10.006_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(01)00287-1","article-title":"Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus","volume":"106","author":"Hajos","year":"2001","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.pharmthera.2010.10.006_bb0315","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1073\/pnas.061029898","article-title":"2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor","volume":"98","author":"Hanus","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2010.10.006_bb0320","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0006-8993(03)03046-4","article-title":"Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain","volume":"983","author":"Hanus","year":"2003","journal-title":"Brain Res"},{"issue":"6","key":"10.1016\/j.pharmthera.2010.10.006_bb0325","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1158\/0008-5472.CAN-03-3720","article-title":"Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE\/ADAM17)-mediated transactivation of the epidermal growth factor receptor","volume":"64","author":"Hart","year":"2004","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.pharmthera.2010.10.006_bb0330","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s00125-006-0343-z","article-title":"A role for kisspeptin in islet function","volume":"49","author":"Hauge-Evans","year":"2006","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.10.006_bb0335","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1096\/fj.08-108670","article-title":"The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation","volume":"23","author":"Henstridge","year":"2009","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0340","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0306-4522(01)00509-7","article-title":"Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain","volume":"109","author":"Hermann","year":"2002","journal-title":"Neuroscience"},{"issue":"22","key":"10.1016\/j.pharmthera.2010.10.006_bb0345","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1016\/j.febslet.2005.08.021","article-title":"P38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells","volume":"579","author":"Herrera","year":"2005","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0350","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"issue":"12","key":"10.1016\/j.pharmthera.2010.10.006_bb0355","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1073\/pnas.122196999","article-title":"An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors","volume":"99","author":"Huang","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0360","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cmet.2009.07.006","article-title":"Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells","volume":"10","author":"Idris","year":"2009","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0365","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2217\/17410541.4.3.307","article-title":"Endocannabinoid system and pathophysiology of adipogenesis: current management of obesity","volume":"4","author":"Iqbal","year":"2007","journal-title":"Personalized Med"},{"issue":"8","key":"10.1016\/j.pharmthera.2010.10.006_bb0370","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1136\/gut.2008.148791","article-title":"Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects","volume":"57","author":"Izzo","year":"2008","journal-title":"Gut"},{"issue":"24","key":"10.1016\/j.pharmthera.2010.10.006_bb0375","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1073\/pnas.96.24.14136","article-title":"Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors","volume":"96","author":"Jarai","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0380","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/jpet.103.057620","article-title":"D-2 dopamine receptors modulate G alpha-subunit coupling of the CB1 cannabinoid receptor","volume":"308","author":"Jarrahian","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.pharmthera.2010.10.006_bb0385","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.neuron.2005.10.021","article-title":"Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit","volume":"48","author":"Jo","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0390","article-title":"Discovery of agonists of the glucose dependent insulinotropic receptor, GPR119, a pancreatic beta-cell GPCR, for the treatment of NIDDM","volume":"31","author":"Jones","year":"2006","journal-title":"Drugs Future"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.10.006_bb0395","first-page":"429","article-title":"Protein kinases, protein phosphorylation, and the regulation of insulin secretion from pancreatic beta-cells","volume":"19","author":"Jones","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0400","series-title":"Islet Function and Insulin Secretion","first-page":"87","author":"Jones","year":"2010"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0405","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ceca.2005.10.005","article-title":"Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic beta-cell","volume":"39","author":"Juan-Pico","year":"2006","journal-title":"Cell Calcium"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0410","first-page":"20","article-title":"Regulation of glucose-induced [Ca2+]i signals by cannabinoid receptors CB1 and CB2 in pancreatic \u03b1- and \u03b4- cells within intact islets of Langerhans","volume":"5","author":"Juan-Pico","year":"2009","journal-title":"Obesity & Metabolism"},{"issue":"43","key":"10.1016\/j.pharmthera.2010.10.006_bb0415","doi-asserted-by":"crossref","first-page":"29817","DOI":"10.1074\/jbc.M109.050187","article-title":"Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands","volume":"284","author":"Kapur","year":"2009","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.pharmthera.2010.10.006_bb0420","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/oby.2009.177","article-title":"Anandamide increases the differentiation of rat adipocytes and causes PPAR[gamma] and CB1 receptor upregulation","volume":"17","author":"Karaliota","year":"2009","journal-title":"Obesity"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.10.006_bb0425","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","article-title":"Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol","volume":"136","author":"Kirkham","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001797","article-title":"The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system","volume":"3","author":"Kola","year":"2008","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0435","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00109-006-0135-4","article-title":"An unexpected new role of mutant Ras: perturbation of human embryonic development","volume":"85","author":"Kratz","year":"2007","journal-title":"J Mol Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0440","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1677\/JOE-08-0453","article-title":"GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis","volume":"201","author":"Lan","year":"2009","journal-title":"J Endocrinol"},{"issue":"52","key":"10.1016\/j.pharmthera.2010.10.006_bb0445","doi-asserted-by":"crossref","first-page":"19144","DOI":"10.1073\/pnas.0509588102","article-title":"The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to G(q\/11) G proteins","volume":"102","author":"Lauckner","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.pharmthera.2010.10.006_bb0450","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.0711278105","article-title":"GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current","volume":"105","author":"Lauckner","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0455","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.bjp.0705607","article-title":"Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors","volume":"141","author":"Leggett","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0460","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.cellbio.12.1.335","article-title":"Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology","volume":"12","author":"Lemberger","year":"1996","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/isl.2.5.12729","article-title":"Expression and function of cannabinoid receptors in mouse islets","volume":"2","author":"Li","year":"2010","journal-title":"Islets"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0470","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000320527","article-title":"Cannabinoid receptors are coupled to stimulation of insulin secretion from mouse MIN6 beta-cells","volume":"26","author":"Li","year":"2010","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0475","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2337\/db09-0979","article-title":"Regulation of MAP kinase-directed mitogenic and protein kinase B-mediated signaling by cannabinoid receptor type 1 in skeletal muscle cells","volume":"59","author":"Lipina","year":"2010","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0480","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.ijo.0802847","article-title":"Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)\/Lep(ob) mice","volume":"29","author":"Liu","year":"2005","journal-title":"Int J Obes"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0485","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.neuroscience.2006.02.024","article-title":"Characterization of CB1 cannabinoid receptor immunoreactivity in postmortem human brain homogenates","volume":"140","author":"Lopez de Jesus","year":"2006","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0490","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0026-895X(25)13215-X","article-title":"Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma-cells","volume":"44","author":"Mackie","year":"1993","journal-title":"Mol Pharmacol"},{"issue":"10","key":"10.1016\/j.pharmthera.2010.10.006_bb0495","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1523\/JNEUROSCI.15-10-06552.1995","article-title":"Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in Att20 cells transfected with rat-brain cannabinoid receptor","volume":"15","author":"Mackie","year":"1995","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0500","doi-asserted-by":"crossref","first-page":"E298","DOI":"10.1208\/aapsj080234","article-title":"Cannabinoid receptors and endocannabinoids: evidence for new players","volume":"8","author":"Mackie","year":"2006","journal-title":"AAPS J"},{"issue":"8","key":"10.1016\/j.pharmthera.2010.10.006_bb0505","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1210\/jc.2005-2679","article-title":"Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia","volume":"91","author":"Matias","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"6284","key":"10.1016\/j.pharmthera.2010.10.006_bb0510","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0515","article-title":"Endogenous ligands for the central and peripheral cannabinoid receptors","volume":"65","author":"Mechoulam","year":"1995","journal-title":"J Neurochem"},{"issue":"47","key":"10.1016\/j.pharmthera.2010.10.006_bb0520","doi-asserted-by":"crossref","first-page":"10707","DOI":"10.1523\/JNEUROSCI.3502-04.2004","article-title":"Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons","volume":"24","author":"Melis","year":"2004","journal-title":"J Neurosci"},{"issue":"7","key":"10.1016\/j.pharmthera.2010.10.006_bb0525","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1073\/pnas.97.7.3655","article-title":"Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human","volume":"97","author":"Mezey","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.10.006_bb0530","doi-asserted-by":"crossref","first-page":"R929","DOI":"10.1152\/ajpregu.90824.2008","article-title":"Adiponectin is required to mediate rimonabant-induced improvement of insulin sensitivity but not body weight loss in diet-induced obese mice","volume":"296","author":"Migrenne","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0535","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2010.08.006","article-title":"Effect of the cannabinoid receptor-1 antagonist on lipolysis in rats","volume":"646","author":"M\u00f8lh\u00f8j","year":"2010","journal-title":"Eur J Pharmacol"},{"issue":"14","key":"10.1016\/j.pharmthera.2010.10.006_bb0540","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2174\/1381612013397366","article-title":"Imidazoline binding sites in the endocrine pancreas: can they fulfil their potential as targets for the development of new insulin secretagogues?","volume":"7","author":"Morgan","year":"2001","journal-title":"Curr Pharm Des"},{"issue":"6441","key":"10.1016\/j.pharmthera.2010.10.006_bb0545","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2010.10.006_bb0550","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.regpep.2007.08.009","article-title":"Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet beta-cells via CB1 receptors","volume":"145","author":"Nakata","year":"2008","journal-title":"Regul Pept"},{"issue":"7","key":"10.1016\/j.pharmthera.2010.10.006_bb0555","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/bjp.2008.337","article-title":"Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells","volume":"155","author":"Ning","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmthera.2010.10.006_bb0560","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","article-title":"Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity","volume":"115","author":"Osei-Hyiaman","year":"2005","journal-title":"J Clin Investig"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.10.006_bb0565","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.bjp.0706218","article-title":"The effects of Delta(9)-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide","volume":"145","author":"O'Sullivan","year":"2005","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0570","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbrc.2005.09.121","article-title":"Novel time-dependent vascular actions of Delta(9)-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma","volume":"337","author":"O'Sullivan","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0575","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2006.02.004","article-title":"Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents","volume":"3","author":"Overton","year":"2006","journal-title":"Cell Metab"},{"issue":"12","key":"10.1016\/j.pharmthera.2010.10.006_bb0580","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1210\/jc.2007-0768","article-title":"The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms","volume":"92","author":"Pagano","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.10.006_bb0585","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1210\/er.2005-0009","article-title":"The emerging role of the endocannabinoid system in endocrine regulation and energy balance","volume":"27","author":"Pagotto","year":"2006","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0590","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbalip.2005.12.011","article-title":"Intestinal levels of anandamide and oleoylethanolamide in food-deprived rats are regulated through their precursors","volume":"1761","author":"Petersen","year":"2006","journal-title":"Biochim Biophys Acta: Mol Cell Biol Lipids"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.10.006_bb0595","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1463-1326.2004.00374.x","article-title":"The anti-obesity effect of rimonabant is associated with an improved serum lipid profile","volume":"7","author":"Poirier","year":"2005","journal-title":"Diab Obes Metab"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0600","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.301.3.1020","article-title":"Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor","volume":"301","author":"Porter","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.10.006_bb0605","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1152\/physrev.1987.67.4.1185","article-title":"Ca2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin-secretion","volume":"67","author":"Prentki","year":"1987","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0610","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0021-9258(18)33114-4","article-title":"Characterization of 1,2-diacylglycerol hydrolysis in human-platelets \u2014 demonstration of an arachidonoyl-monoacylglycerol intermediate","volume":"258","author":"Prescott","year":"1983","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0615","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00125-005-0101-7","article-title":"Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans","volume":"49","author":"Ramracheya","year":"2006","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.10.006_bb0620","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1189\/jlb.0505274","article-title":"Induction of intracellular calcium elevation by Delta(9)-tetrahydrocannabinol in T cells involves TRPC1 channels","volume":"79","author":"Rao","year":"2006","journal-title":"J Leukoc Biol"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.10.006_bb0625","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/sj.ijo.0802583","article-title":"CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity","volume":"28","author":"Ravinet Trillou","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.10.006_bb0630","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuropharm.2007.05.024","article-title":"Methanandamide activation of a novel current in mouse trigeminal ganglion sensory neurons in vitro","volume":"54","author":"Roberts","year":"2008","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0635","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1677\/JOE-08-0397","article-title":"Rapid non-genomic regulation of Ca2+ signals and insulin secretion by PPAR alpha ligands in mouse pancreatic islets of Langerhans","volume":"200","author":"Ropero","year":"2009","journal-title":"J Endocrinol"},{"issue":"5","key":"10.1016\/j.pharmthera.2010.10.006_bb0640","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.bjp.0705467","article-title":"Anandamide and vanilloid TRPV1 receptors","volume":"140","author":"Ross","year":"2003","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.10.006_bb0645","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s002130100749","article-title":"Cross tolerance between anorectic action and induction of Fos-ir with dexfenfluramine and 5HT(1B\/2C) agonists in rats","volume":"156","author":"Rowland","year":"2001","journal-title":"Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2010.10.006_bb0650","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0169-328X(02)00174-2","article-title":"The cannabinoid agonist DALN dependent calcium-channels positively modulates L-type voltage-in N18TG2 neuroblastoma cells","volume":"101","author":"Rubovitch","year":"2002","journal-title":"Mol Brain Res"},{"issue":"7","key":"10.1016\/j.pharmthera.2010.10.006_bb0655","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmthera.2010.10.006_bb0660","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1124\/mol.54.5.834","article-title":"Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta(9)-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes","volume":"54","author":"Sanchez","year":"1998","journal-title":"Mol Pharmacol"},{"issue":"9","key":"10.1016\/j.pharmthera.2010.10.006_bb0665","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0898-6568(03)00036-6","article-title":"Activation of phosphoinositide 3-kinase\/PKB pathway by CB1 and CB2 cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction","volume":"15","author":"Sanchez","year":"2003","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0670","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.2337\/diabetes.53.suppl_3.S79","article-title":"Effect of PPAR-gamma activation and inhibition on glucose-stimulated insulin release in INS-1e cells","volume":"53","author":"Santini","year":"2004","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0675","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0169-328X(98)00277-0","article-title":"Identification and cloning of three novel human G protein-coupled receptor genes GPR52, Psi GPR53 and GPR55: GPR55 is extensively expressed in human brain","volume":"64","author":"Sawzdargo","year":"1999","journal-title":"Mol Brain Res"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.10.006_bb0680","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.beem.2007.08.005","article-title":"Cannabinoid-1 receptor antagonists in type-2 diabetes","volume":"21","author":"Scheen","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.10.006_bb0685","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.beem.2008.09.001","article-title":"Use of cannabinoid CB1 receptor antagonists for the treatment of metabolic disorders","volume":"23","author":"Scheen","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2010.10.006_bb0690","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.2337\/diabetes.53.suppl_3.S59","article-title":"Integration of ATP, cAMP, and Ca2+ signals in insulin granule exocytosis","volume":"53","author":"Shibasaki","year":"2004","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0695","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1124\/jpet.104.067249","article-title":"Fenofibrate, troglitazone, and 15-deoxy-Delta(12,14)-prostaglandin J(2) close K-ATP channels and induce insulin secretion","volume":"310","author":"Shimomura","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.10.006_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/S0165-6147(00)01459-0","article-title":"Anandamide: an endogenous activator of the vanilloid receptor","volume":"21","author":"Smart","year":"2000","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0705","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/sj.bjp.0704732","article-title":"\u2018Entourage\u2019 effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism","volume":"136","author":"Smart","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.10.006_bb0710","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bbrc.2004.11.120","article-title":"Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor","volume":"326","author":"Soga","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.pharmthera.2010.10.006_bb0715","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-2236(99)01447-2","article-title":"The dopamine hypothesis of reward: past and current status","volume":"22","author":"Spanagel","year":"1999","journal-title":"Trends Neurosci"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.10.006_bb0720","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/oby.2007.106","article-title":"Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet","volume":"16","author":"Starowicz","year":"2008","journal-title":"Obesity"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.10.006_bb0725","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/oxfordjournals.jbchem.a021838","article-title":"Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells","volume":"122","author":"Sugiura","year":"1997","journal-title":"J Biochem"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.10.006_bb0730","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/bbrc.1996.1757","article-title":"2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma X glioma hybrid NG108-15 cells","volume":"229","author":"Sugiura","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.10.006_bb0735","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1074\/jbc.275.1.605","article-title":"Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor \u2014 comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells","volume":"275","author":"Sugiura","year":"2000","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.10.006_bb0740","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylgylcerol \u2014 a possible endogenous cannabinoid receptor\u2013ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2010.10.006_bb0745","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0009-3084(00)00189-4","article-title":"2-Arachidonoylglycerol and the cannabinoid receptors","volume":"108","author":"Sugiura","year":"2000","journal-title":"Chem Phys Lipids"},{"issue":"8","key":"10.1016\/j.pharmthera.2010.10.006_bb0750","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1172\/JCI42551","article-title":"Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity","volume":"120","author":"Tam","year":"2010","journal-title":"J Clin Investig"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.10.006_bb0755","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bbrc.2008.05.077","article-title":"The cannabinoid CB1 receptor is expressed in pancreatic delta-cells","volume":"372","author":"Tharp","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"5746","key":"10.1016\/j.pharmthera.2010.10.006_bb0760","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0765","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0022-3565(24)38790-7","article-title":"Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries","volume":"296","author":"Vanheel","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.10.006_bb0770","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.beem.2008.10.002","article-title":"The role of the endocannabinoid system in lipogenesis and fatty acid metabolism","volume":"23","author":"Vettor","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2010.10.006_bb0775","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.regpep.2010.04.013","article-title":"CB1 cannabinoid receptor expression is regulated by glucose and feeding in rat pancreatic islets","volume":"163","author":"Vilches-Flores","year":"2010","journal-title":"Regul Pept"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.10.006_bb0780","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1523\/JNEUROSCI.23-04-01398.2003","article-title":"Nonpsychotropic cannabinoid receptors regulate microglial cell migration","volume":"23","author":"Walter","year":"2003","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0785","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0031-9384(02)00725-4","article-title":"Observational analysis of feeding induced by Delta(9)-THC and anandamide","volume":"76","author":"Williams","year":"2002","journal-title":"Physiol Behav"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.10.006_bb0790","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.gastro.2005.05.026","article-title":"Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing","volume":"129","author":"Wright","year":"2005","journal-title":"Gastroenterology"},{"issue":"6743","key":"10.1016\/j.pharmthera.2010.10.006_bb0795","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nature"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725810002135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725810002135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T15:47:58Z","timestamp":1740671278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725810002135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":159,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0163725810002135"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2010.10.006","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}